Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53.

Kathleen Forrester(National Institutes of Health), Stefan Ambs(National Institutes of Health), Shawn E. Lupold(National Institutes of Health), Rachel B. Kapust(National Institutes of Health), Elisa A. Spillare(National Institutes of Health), Wendy C. Weinberg(National Institutes of Health), Emanuela Felley‐Bosco(National Institutes of Health), Xin Wei Wang(National Institutes of Health), David A. Geller(National Institutes of Health), Edith Tzeng(National Institutes of Health), Timothy R. Billiar(National Institutes of Health), C C Harris(National Institutes of Health)
Proceedings of the National Academy of Sciences
March 19, 1996
Cited by 466Open Access

Abstract

The tumor suppressor gene product p53 plays an important role in the cellular response to DNA damage from exogenous chemical and physical mutagens. Therefore, we hypothesized that p53 performs a similar role in response to putative endogenous mutagens, such as nitric oxide (NO). We report here that exposure of human cells to NO generated from an NO donor or from overexpression of inducible nitric oxide synthase (NOS2) results in p53 protein accumulation. In addition, expression of wild-type (WT) p53 in a variety of human tumor cell lines, as well as murine fibroblasts, results in down-regulation of NOS2 expression through inhibition of the NOS2 promoter. These data are consistent with the hypothesis of a negative feedback loop in which endogenous NO-induced DNA damage results in WT p53 accumulation and provides a novel mechanism by which p53 safeguards against DNA damage through p53-mediated transrepression of NOS2 gene expression, thus reducing the potential for NO-induced DNA damage.


Related Papers

No related papers found

Powered by citation graph analysis